ArticleJournal of cachexia, sarcopenia and muscle2025
CircGLIS3 Inhibits Intramuscular Adipogenesis and Alleviates Skeletal Muscle Fat Infiltration.
Article in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Novel biomarkers for sarcopenia: a narrative review.Journal of orthopaedic surgery and research · 2026Review
- HMGB2-RAD21 Axis Promotes Fibro/Adipogenic Progenitor Proliferation and Regulates Fat Infiltration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- RNA sequencing reveals lncRNAs that specifically regulate unsaturated fatty acid generation in buffaloes.Archives animal breeding · 2026Article
- CircGLIS3 Inhibits Intramuscular Adipogenesis and Alleviates Skeletal Muscle Fat Infiltration.Journal of cachexia, sarcopenia and muscle · 2025Article
- Stromal cells unifying the pathology of acute and chronic skeletal muscle injury - clue for novel biomaterials.Frontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundIntramuscular fat (IMF) is a key determinant of meat quality. Excessive IMF deposition, commonly observed in human obesity and aging, negatively affects skeletal muscle function. Circular RNAs (circRNAs) play critical regulatory roles in muscle and fat development, as well as in the progression of related diseases. However, the specific functions and underlying mechanisms of circRNAs in IMF deposition have not been extensively studied.
methodsWe screened adipogenic differentiation-related circRNAs using circRNA-seq combined with WGCNA. Functional analyses, including loss-of-function and gain-of-function experiments, were performed to determine the role of circGLIS3 in regulating adipogenesis in bovine intramuscular preadipocytes and 3T3-L1 cells. A high-fat diet-induced mouse model was established to investigate the in vivo effects of circGLIS3 on skeletal muscle fat infiltration in mice (C57BL/6; n = 6 males). Mechanistic studies involved transcriptomic analysis, dual-luciferase reporter assays, RNA immunoprecipitation, and rescue experiments.
resultsWe screened and characterized a novel circRNA, circGLIS3, which is highly expressed in bovine IMF tissue and in the skeletal muscle of mice exhibiting fat infiltration. Functionally, circGLIS3 overexpression inhibited triglyceride synthesis (-16.19%, p < 0.01) and lipid droplet accumulation (-42.44%, p < 0.01) in intramuscular preadipocytes, concurrently downregulating the expression of key adipogenesis-related genes and proteins (p < 0.05). CircGLIS3 knockdown promoted triglyceride synthesis (+28.32%, p < 0.05) and lipid droplet accumulation (+47.40%, p < 0.01) in intramuscular preadipocytes, accompanied by a significant upregulation of adipogenesis-related genes and proteins (p < 0.05). Notably, circGLIS3 exhibits more than 80% sequence homology among bovine, mouse, and human species. CircGLIS3 overexpression inhibited triglyceride synthesis (-28.84%, p < 0.01) and lipid droplet accumulation (-46.49%, p < 0.01) in 3T3-L1 cells, concurrently downregulating the expression of adipogenesis-related genes and proteins (p < 0.05). Overexpression of circGLIS3 reduced skeletal muscle fat infiltration induced by high-fat diet in mice (-57.88%, p < 0.05). Mechanistically, circGLIS3 acts as a sponge for miR-21-3p, increasing the expression of its target gene, LEPR (+56.05%, p < 0.01), and promoting the phosphorylation level of its downstream signalling protein, AMPKα (+68.68%, p < 0.01).
conclusionsCircGLIS3 inhibits bovine intramuscular adipogenesis by regulating the miR-21-3p/LEPR/AMPK axis, reducing fat infiltration in mouse skeletal muscle. These findings suggest that circGLIS3 is a promising target for improving meat quality in livestock, and as a potential therapeutic marker for alleviating skeletal muscle fat infiltration associated with obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.